FDA Considers Approval for Moderna's mRNA Flu Vaccine

Why it matters locally: While not directly tied to a specific West Virginia industry, the approval of a new type of flu vaccine could influence public health strategies and vaccine accessibility for residents statewide.

The Food and Drug Administration (FDA) is preparing to issue a ruling on Moderna's messenger RNA (mRNA) flu vaccine. This vaccine, if approved, would become the first mRNA-based influenza shot available commercially. Observers expect the FDA's decision to affect the biotechnology industry broadly.